0OCD.LSE

Medistim ASA

0OCD.LSE, UK

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Europe, Asia, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which is designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation of fragile or calcified vessels; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.

https://www.medistim.com

Stock Price

NOK0.00

0%

increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
0OCD.LSE
stock
0OCD.LSE

Ocado Share Price (OCDO) London South East

Read more →

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Earnings Ratio (P/E)

-

Very High

0.52

Low ≥ 50

High ≤ 10

Price to Book Ratio (P/B)

-

Very High

11.44

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

8.29 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Medium

6.04 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very High

41.41 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very High

0.37

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 0.00% of the total shares of Medistim ASA

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

1.45

Latest Release

Date

2024-03-31

EPS Actual

1.3312

EPS Estimate

—

EPS Difference

0

Surprise Percent

0%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Strong Deep Value(7.5)
Defensive
Moderately Defensive(5.5)
Dividend
Decent Dividend Payer(3.5)
Economic Moat
Wide Moat Company(9)
GARP
Fair GARP(4)
Growth
Weak Growth Prospect(3)
Momentum
Moderate Momentum(4)
Net Net
Possible Net-Net(4)
Quality
High Quality(8.5)
Value
Undervalued(7)

Income Statement

(Last Updated 2025-09-30)

Revenue

NOK 0

Cost Of Revenue

NOK 0

Gross Profit

NOK 0

Operating Expenses

NOK 0

Operating Income

NOK 0

Interest Expense

NOK 0

Pretax Income

NOK 0

Net Income

NOK 0

Income Tax Expense

NOK 0

EBITDA

NOK 0

Total Other Income Expense Net

NOK 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

NOK 0

Short Term Investments

NOK 0

Receivables

NOK 0

Inventories

NOK 0

Total Current Assets

NOK 0

Property Plant Equipment

NOK 0

Total Assets

NOK 0

Payables

NOK 0

Short Term Debt

NOK 0

Long Term Debt

NOK 0

Total Liabilities

NOK 0

Equity

NOK 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

NOK 0

Depreciation

NOK 0

Change In Working Capital

NOK 0

Cash From Operations

NOK 0

Capital Expenditures

NOK 0

Cash From Investing

NOK 0

Cash From Financing

NOK 0

Net Change In Cash

NOK 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.